Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clotrimazole Troches vs. Mycelex in HIV Patients with Oropharyngeal Candidiasis
NCT02184351Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- May 2001
- Primary completion
- Nov 2001
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of clotrimazole in oropharyngeal candidiasis (OPC), sponsored by Boehringer Ingelheim. Started May 2001; status: completed.
02
Drugs
clotrimazole
03
Conditions
oropharyngeal candidiasis (OPC)
Beyond the preview
Go deeper on NCT02184351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02184351.